MRK•benzinga•
Leerink Partners Maintains Outperform on Merck & Co, Lowers Price Target to $119
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 13, 2025 by benzinga